KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $882,650 | -2.0% | 5,220 | +25.7% | 0.00% | 0.0% |
| Q2 2023 | $900,578 | +38.8% | 4,153 | +16.3% | 0.00% | +33.3% |
| Q1 2023 | $648,818 | +0.3% | 3,572 | +8.5% | 0.00% | 0.0% |
| Q4 2022 | $646,682 | -20.7% | 3,291 | -9.2% | 0.00% | -40.0% |
| Q3 2022 | $815,000 | +573.6% | 3,624 | +277.5% | 0.01% | +400.0% |
| Q2 2022 | $121,000 | -2.4% | 960 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $124,000 | +27.8% | 977 | +32.0% | 0.00% | – |
| Q4 2021 | $97,000 | +155.3% | 740 | +137.9% | 0.00% | – |
| Q3 2021 | $38,000 | +8.6% | 311 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -5.4% | 311 | 0.0% | 0.00% | – |
| Q1 2021 | $37,000 | +15.6% | 311 | 0.0% | 0.00% | – |
| Q4 2020 | $32,000 | +33.3% | 311 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |